Large-scale testing (Phase 3)Ended earlyNCT00616902
What this trial is testing
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Who this might be right for
Chronic Kidney Disease (CKD) Stage 5Hypertrophy, Left Ventricular
Abbott 12